BioForce Nanosciences (OTCMKTS:BFNH – Get Free Report) released its quarterly earnings data on Monday. The company reported $0.01 EPS for the quarter, Zacks reports.
BioForce Nanosciences Price Performance
Shares of OTCMKTS:BFNH opened at $2.42 on Wednesday. BioForce Nanosciences has a 1 year low of $0.18 and a 1 year high of $2.47. The company has a market cap of $81.19 million, a PE ratio of 242.24 and a beta of -0.52. The stock’s 50-day moving average is $1.62 and its 200 day moving average is $0.95.
BioForce Nanosciences Company Profile
BioForce Nanosciences, Inc develops and markets precision instrumentation and proprietary technologies for the production and application of nanoscale materials. Its core platform employs nozzle-driven electrohydrodynamic processes to generate and deposit nanofibers, nanowires and nanoparticles with tight control over diameter, morphology and spatial arrangement. By tailoring electric field parameters and solution properties, the technology enables reproducible fabrication of structures at the nanometer scale.
The company’s product portfolio includes desktop electrospinning systems for nanofiber fabrication, electrospray modules for nanoparticle synthesis and integrated tools for bioprinting and surface patterning.
Further Reading
- Five stocks we like better than BioForce Nanosciences
- Hims & Hers’ Revenue Beat Came With a Profitability Problem
- A Westinghouse IPO Could Reset the Nuclear Stock Conversation
- Fastly’s Q2 Rally Shows Investors Are Buying the Edge AI Turnaround
- Paramount’s 30-Film Promise Puts AMC Back in the Box Office Conversation
Receive News & Ratings for BioForce Nanosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioForce Nanosciences and related companies with MarketBeat.com's FREE daily email newsletter.
